LexaGene Holdings (LXG.V) started the new year strong by selling more of their proprietary MiQLab systems to three veterinary clinics in Michigan, Minnesota and New York.
The MiQLab is an automated polymerase chain reaction (PCR) based system used for testing in both human and veterinary diagnostics, as well as food safety testing and testing markets that need time sensitive answers.
“I’m pleased that we are making headway in the veterinary diagnostics marketplace. By acquiring MiQLab Systems, veterinary practices are setting themselves apart from their competition, as this technology allows them to elevate the standard of care they provide to companion animals. We look forward to educating veterinary practices in the coming year, regarding the importance of in-clinic PCR testing, and aim to revolutionize veterinary diagnostics through the sale of MiQLab Systems. No longer should veterinary practices empirically diagnosis our companion animals or send samples off to labs only to wait days or weeks for results when they can have a treatment plan in a fraction of the time,” said Dr Jack Regan, LexaGene’s founder and CEO.
Lexagene is a healthcare tech company that develops molecular diagnostic systems for pathogen detection and genetic testing for molecular markers for on-site rapid testing for veterinary diagnostics and food safety. The markets these serve as clinical research, agricultural testing, and biodefence.
“My team is diligently engaged with numerous veterinary practices, both private and corporate. Many of the veterinarians we have spoken to share our excitement over the value of in-clinic PCR testing and the capabilities that the MiQLab System can provide to their practices. It is gratifying to welcome 2022 with a strong start and continue our momentum as we work on closing additional sales,” said Julie Griggs, LexaGene’s global director of sales.
- Samples are loaded with less than one minute of hands-on time onto the system with a single-use disposable sample preparation cartridge, allowing the user to simply press ‘Run Test’ to initiate sample processing for walk-away testing.
- The MiQLab system draws each liquid sample into a sample preparation cartridge, where microbes are concentrated and lysed before their genetic material is purified. The system then pulls the purified genomic material from inside the cartridge into the system’s microfluidics where a series of real-time PCR reaction mixtures are assembled, highly multiplex qPCR reactions are amplified, and the results are analyzed.
- A total of 10 reactions are assembled, the first of which is a negative control, so the operator has confidence in the results. The remaining 9 four-plex real-time PCR reactions each have an internal process control to confirm sample preparation worked and the fluidics merged the reaction mixtures successfully.
- MiQLab tests for 27 targets at once and delivers results in approximately 2 hours. The system can report results electronically to a mobile device, computer, or record keeping system.
Technically the markets are closed today in Canada due to the stat holiday, but this company will still be around tomorrow if you’re looking for something interesting to help pad your portfolio.
—Joseph Morton
